The trademark application PHAGESELECT was filed by Adaptive Phage Therapeutics, Inc., a U.S. corporation (the "Applicant"). Application refused.
The application was filed in English (French was selected as the second language).
The Refusal with reference B 018688018 was Rejected according to Article 7(1)(b) EUTMR with decision issued on October 23, 2022 by the EUIPO.
Goods And Services
The mark was filed in class 42 with Providing non-downloadable computer software application in the field of personalized medicine to provide medical and diagnostic services involving bacterial infections.
The mark was filed in class 44 with following description of goods:
Medical testing for diagnostic or treatment purposes in the field of personalized medicine
Health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes
Clinical and medical laboratory testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine.